HK1018274A1 - Oxa- and thia-diazole muscarinic receptor antagonists - Google Patents

Oxa- and thia-diazole muscarinic receptor antagonists

Info

Publication number
HK1018274A1
HK1018274A1 HK99103379A HK99103379A HK1018274A1 HK 1018274 A1 HK1018274 A1 HK 1018274A1 HK 99103379 A HK99103379 A HK 99103379A HK 99103379 A HK99103379 A HK 99103379A HK 1018274 A1 HK1018274 A1 HK 1018274A1
Authority
HK
Hong Kong
Prior art keywords
diazole
thia
oxa
receptor antagonists
muscarinic receptor
Prior art date
Application number
HK99103379A
Other languages
English (en)
Inventor
Alexander Roderick Mackenzie
Anthony Wood
Robert John Bass
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of HK1018274A1 publication Critical patent/HK1018274A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK99103379A 1996-02-22 1999-08-05 Oxa- and thia-diazole muscarinic receptor antagonists HK1018274A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603755.1A GB9603755D0 (en) 1996-02-22 1996-02-22 Therapeutic agents
PCT/EP1997/000525 WO1997030994A1 (en) 1996-02-22 1997-02-04 Oxa- and thia-diazole muscarinic receptor antagonists

Publications (1)

Publication Number Publication Date
HK1018274A1 true HK1018274A1 (en) 1999-12-17

Family

ID=10789217

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99103379A HK1018274A1 (en) 1996-02-22 1999-08-05 Oxa- and thia-diazole muscarinic receptor antagonists

Country Status (43)

Country Link
US (1) US5977142A (zh)
EP (1) EP0885218B1 (zh)
JP (1) JP3148252B2 (zh)
KR (1) KR100315934B1 (zh)
CN (1) CN1089340C (zh)
AP (1) AP751A (zh)
AR (1) AR005916A1 (zh)
AT (1) ATE200899T1 (zh)
AU (1) AU712230B2 (zh)
BG (2) BG63971B1 (zh)
BR (1) BR9707733A (zh)
CA (1) CA2247164C (zh)
CO (1) CO4650040A1 (zh)
CZ (1) CZ292650B6 (zh)
DE (1) DE69704701T2 (zh)
DK (1) DK0885218T3 (zh)
DZ (1) DZ2181A1 (zh)
ES (1) ES2156357T3 (zh)
GB (1) GB9603755D0 (zh)
GR (1) GR3036032T3 (zh)
HK (1) HK1018274A1 (zh)
HN (1) HN1997000020A (zh)
HR (1) HRP970098B1 (zh)
HU (1) HUP9900501A3 (zh)
ID (1) ID16642A (zh)
IL (1) IL125413A (zh)
IS (1) IS4803A (zh)
MY (1) MY129729A (zh)
NO (1) NO313414B1 (zh)
NZ (1) NZ331039A (zh)
OA (1) OA10838A (zh)
PE (1) PE42798A1 (zh)
PL (1) PL186879B1 (zh)
PT (1) PT885218E (zh)
RU (1) RU2162848C2 (zh)
SK (1) SK283461B6 (zh)
TN (1) TNSN97039A1 (zh)
TR (1) TR199801644T2 (zh)
TW (1) TW492961B (zh)
UA (1) UA61068C2 (zh)
WO (1) WO1997030994A1 (zh)
YU (1) YU35698A (zh)
ZA (1) ZA971513B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
GB0510139D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
GB0510141D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
GB0516313D0 (en) * 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
WO2008017827A2 (en) * 2006-08-08 2008-02-14 Argenta Discovery Limited Azole and thiazole derivatives and their uses
WO2008023157A1 (en) * 2006-08-21 2008-02-28 Argenta Discovery Limited Nitrogen containing heterocyclic compounds useful as m3-receptor modulators
WO2008096093A1 (en) * 2007-02-06 2008-08-14 Argenta Discovery Ltd. Oxazole and thiazole derivatives and their uses
GB0702385D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
GB0702414D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd Oxazole and thiazole derivatives and their uses 2
MX2009008364A (es) * 2007-02-07 2009-08-20 Astrazeneca Ab Sal de napadisilato de un antagonista m3 muscarinico.
GB0702382D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New salt
GB0702416D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
AU2008215924B2 (en) * 2007-02-15 2011-04-21 Pulmagen Therapeutics (Synergy) Limited Heterocyclic derivatives as M3 muscarinic receptors
WO2009098453A1 (en) * 2008-02-06 2009-08-13 Astrazeneca Ab Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists
US8263623B2 (en) 2008-07-11 2012-09-11 Pfizer Inc. Triazol derivatives useful for the treatment of diseases
WO2010018352A1 (en) * 2008-08-12 2010-02-18 Argenta Discovery Limited Heterocyclic compounds used in the treatment of diseases where enhanced m3 receptor activation is implicated
JP2014065387A (ja) * 2012-09-25 2014-04-17 Showa Corp 自動二輪車の車高調整装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
IL88846A0 (en) * 1988-01-08 1989-07-31 Merck Sharp & Dohme Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
AU3171493A (en) * 1991-12-31 1993-07-28 Fujisawa Pharmaceutical Co., Ltd. Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity
TW360653B (en) * 1995-03-01 1999-06-11 Janssen Pharmaceutica Nv A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition

Also Published As

Publication number Publication date
HUP9900501A2 (hu) 1999-06-28
KR19990087143A (ko) 1999-12-15
RU2162848C2 (ru) 2001-02-10
NO983871D0 (no) 1998-08-21
TW492961B (en) 2002-07-01
US5977142A (en) 1999-11-02
YU35698A (sh) 1999-07-28
EP0885218A1 (en) 1998-12-23
CA2247164A1 (en) 1997-08-28
WO1997030994A1 (en) 1997-08-28
KR100315934B1 (ko) 2002-03-21
PE42798A1 (es) 1998-08-18
CZ267898A3 (cs) 1999-08-11
JP3148252B2 (ja) 2001-03-19
IS4803A (is) 1998-07-21
ES2156357T3 (es) 2001-06-16
HUP9900501A3 (en) 2001-02-28
IL125413A (en) 2002-09-12
EP0885218B1 (en) 2001-05-02
GR3036032T3 (en) 2001-09-28
TNSN97039A1 (fr) 2005-03-15
DZ2181A1 (fr) 2002-12-01
AR005916A1 (es) 1999-07-21
CN1089340C (zh) 2002-08-21
AU1601497A (en) 1997-09-10
ATE200899T1 (de) 2001-05-15
DE69704701T2 (de) 2001-08-16
CO4650040A1 (es) 1998-09-03
AP751A (en) 1999-07-12
NO313414B1 (no) 2002-09-30
BG63971B1 (bg) 2003-08-29
GB9603755D0 (en) 1996-04-24
DK0885218T3 (da) 2001-05-28
AP9700930A0 (en) 1997-04-30
ZA971513B (en) 1998-08-21
CZ292650B6 (cs) 2003-11-12
IL125413A0 (en) 1999-03-12
UA61068C2 (en) 2003-11-17
JPH11504051A (ja) 1999-04-06
ID16642A (id) 1997-10-23
HRP970098A2 (en) 1999-04-30
NZ331039A (en) 1999-10-28
MY129729A (en) 2007-04-30
OA10838A (en) 2001-08-13
PT885218E (pt) 2001-08-30
TR199801644T2 (xx) 1998-11-23
NO983871L (no) 1998-08-21
PL328633A1 (en) 1999-02-15
CA2247164C (en) 2004-11-16
AU712230B2 (en) 1999-11-04
DE69704701D1 (de) 2001-06-07
BR9707733A (pt) 1999-07-27
CN1211981A (zh) 1999-03-24
HRP970098B1 (en) 2001-12-31
SK283461B6 (sk) 2003-08-05
PL186879B1 (pl) 2004-03-31
HN1997000020A (es) 1997-06-05
SK112398A3 (en) 2000-04-10
BG102699A (en) 1999-09-30

Similar Documents

Publication Publication Date Title
PL331534A1 (en) Muscarinic antagonists
CY2576B1 (en) Vitronectin receptor antagonists
HU9603525D0 (en) Vironectin receptor antagonists
EP0912175A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
GB9020051D0 (en) Muscarinic receptor antagonists
SG80041A1 (en) Muscarinic receptor antagonists
IL130760A0 (en) Vitronectin receptor antagonists
EP0885205A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0880511A4 (en) INTEGRIN RECEPTOR ANTAGONISTS
ZA971513B (en) Oxa-and thia-diazole muscarinic receptor antagonists
EP0885213A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
IL140249A0 (en) Muscarinic antagonists
IL135028A0 (en) Vitronectin receptor antagonists
GB9600344D0 (en) Benzimidzolyl neuropeptide y receptor antagonists
EP0957908A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
ZA200003475B (en) Muscarinic receptor antagonists.
SI0957917T1 (sl) Antagonisti receptorja vitronektina
ZA961293B (en) Muscarinic antagonists
GB9603371D0 (en) Fibrinogen receptor antagonists
GB9606489D0 (en) Fibrinogen receptor antagonists
GB9613688D0 (en) Fibrinogen receptor antagonists
IL119820A0 (en) Integrin receptor antagonists
GB9603373D0 (en) Integrin receptor antagonists
GB9702834D0 (en) Fibrinogen receptor antagonists
EP1001777A4 (en) Fibrinogen Receptor Antagonists

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070204